Glessner Coleen 4
4 · Emergent BioSolutions Inc. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Glessner Coleen
EVP, Quality & Ethics, and CPL
Transactions
- Tax Payment
Common Stock
[F1]2026-03-05$8.44/sh−8,199$69,200→ 104,108 total - Award
Employee Stock Option (Right to buy)
[F2]2026-03-03+44,834→ 294,447 totalExercise: $8.99Exp: 2033-03-02→ Common Stock (44,834 underlying)
Footnotes (2)
- [F1]Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units
- [F2]Vests in three equal installments beginning on the day prior to the anniversary date of the grant.
Signature
/s/ Richard S. Lindahl, Attorney-in-fact|2026-03-05